Corcept Therapeutics · 9 hours ago
Clinical Development Intern
Redwood City, California, United States
Internship
Onsite
Intern
$26/hr - $32/hr
Start in 2026 SummerCorcept Therapeutics is a leading company in the research and development of cortisol modulators. The Clinical Development Intern will support the Clinical Development team in advancing neurology and oncology programs through contributions to clinical development strategy, trial design, and execution.
BiotechnologyMedicalPharmaceutical
No H1B
Responsibilities
Support literature reviews on neurology or oncology disease areas, treatment landscapes and emerging therapies
Support data review, analysis and interpretation from ongoing clinical trials, as appropriate
Participate in cross-functional team meetings
Network with other professionals and colleagues across the organization
Deliver a department presentation at the end of the program
Participate as a member of the 2026 intern team group project that includes a company-wide presentation
Qualification
Required
Support literature reviews on neurology or oncology disease areas, treatment landscapes and emerging therapies
Support data review, analysis and interpretation from ongoing clinical trials, as appropriate
Participate in cross-functional team meetings
Network with other professionals and colleagues across the organization
Deliver a department presentation at the end of the program
Participate as a member of the 2026 intern team group project that includes a company-wide presentation
Must be able to complete at least 10 consecutive weeks between June and August and it is a full-time internship (40 hours per week)
Must be able to work at our Redwood City office for the duration of the internship, no relocation available
Applicants must be currently authorized to work in the United States on a full-time basis
Preferred
Basic knowledge of clinical research and clinical trial regulations
Strong analytical and problem-solving skills
Ability to work independently and collaboratively in a dynamic team environment
Currently enrolled in a graduate program (PharmD, MD, PhD) in a health-related field
Company
Corcept Therapeutics
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
Founded in 1998
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$119.09MKey Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M
Leadership Team
Roberto Vieira
President, Oncology
Yuan Xu
Associate Director, Statistical Programming
Recent News
Company data provided by crunchbase